Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Gains from Sales and Divestitures (2016 - 2025)

National Research's Gains from Sales and Divestitures history spans 7 years, with the latest figure at $43000.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures changed N/A year-over-year to $43000.0; the TTM value through Dec 2025 reached $43000.0, changed N/A, while the annual FY2025 figure was $43000.0, N/A changed from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $43000.0 at National Research, down from $71378.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $43000.0 in Q4 2025 and bottomed at $43000.0 in Q4 2025.